BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 559613)

  • 1. [Treatment of threatened abortion with Gravibinan].
    Sternadel Z; Peksa A; Witkowska E; Kwiatkowska Z
    Ginekol Pol; 1977 May; 48(5):509-12. PubMed ID: 559613
    [No Abstract]   [Full Text] [Related]  

  • 2. [Gravibinan in the treatment of threatened abortion].
    Krzysiek J; Milewicz S; Paradysz A
    Ginekol Pol; 1976 Mar; 47(3):321-5. PubMed ID: 943363
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hormone therapy of threatened abortion].
    Stojanov S
    Zentralbl Gynakol; 1972 Oct; 94(40):1323-6. PubMed ID: 4118064
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of habitual abortion with caprovestrol].
    Kovtumova LG; Turbina ZV; Rymashevskaia EP; Zelenkova LT
    Vopr Okhr Materin Det; 1976 May; 21(5):72-5. PubMed ID: 1027289
    [No Abstract]   [Full Text] [Related]  

  • 5. [Letter: Are progestational agents indicated in threatened abortion?].
    Wildschut J
    Ned Tijdschr Geneeskd; 1976 Feb; 120(7):296-7. PubMed ID: 1250470
    [No Abstract]   [Full Text] [Related]  

  • 6. [The treatment of threatened abortion (author's transl)].
    Berle P; Behnke K
    Geburtshilfe Frauenheilkd; 1977 Feb; 37(2):139-42. PubMed ID: 320090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hormone therapy of spontaneous abortion. Our experience with treatment with Gravibinan].
    Drazancić A; Latin V
    Jugosl Ginekol Opstet; 1978; 18(3-4):325-33. PubMed ID: 757251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Action of a natural progesterone associated with a synthetic progestogen and vitamin E in the treatment of threatened abortion and premature labor].
    Panariello S
    Arch Ostet Ginecol; 1970 Dec; 75(6):492-506. PubMed ID: 5526026
    [No Abstract]   [Full Text] [Related]  

  • 9. [Own observations on hormone therapy in threatening prematurity].
    Antonopoulos D; Moskovakis K
    Arch Gynakol; 1967; 204(2):117-8. PubMed ID: 5631114
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hormone therapy of threatened abortion during the early stages of pregnancy].
    Trepechov S; Shturkalev I
    Akush Ginekol (Sofiia); 1972; 11(2):152-60. PubMed ID: 4651074
    [No Abstract]   [Full Text] [Related]  

  • 11. [The study of the effectiveness of 17-alpha-hydroxyprogesterone capronate in the treatment of threatened abortion].
    Kubinyi J; Pilishegyi J
    Orv Hetil; 1969 Mar; 110(12):654-5. PubMed ID: 4889626
    [No Abstract]   [Full Text] [Related]  

  • 12. [Is there any evidence that the maternal HPL serum-concentration is of prognostic value in cases of threatened abortion? (author's transl)].
    Berle P; Behnke K
    Z Geburtshilfe Perinatol; 1977 Jun; 181(3):211-7. PubMed ID: 888497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pregnancy in surgery].
    Jütting G; Jung H
    Chirurg; 1971 Dec; 42(12):529-34. PubMed ID: 5136173
    [No Abstract]   [Full Text] [Related]  

  • 14. [Assessment of the obstetric application of 17-hydroxyprogesterone capronate (Hormofort)].
    Németi S; Veres L; Balázsy T; Surányi S
    Orv Hetil; 1970 Jun; 111(24):1404-7. PubMed ID: 5454025
    [No Abstract]   [Full Text] [Related]  

  • 15. A double-blind study of progestogen treatment in spontaneous abortion. (Preliminary report).
    Govaerts-Videtzky M; Martin L; Hubinont PO
    J Obstet Gynaecol Br Commonw; 1965 Dec; 72(6):1034. PubMed ID: 5324459
    [No Abstract]   [Full Text] [Related]  

  • 16. Retinal arteriolar obstruction with progestogen treatment of threatened abortion.
    Lanzetta P; Crovato S; Pirracchio A; Bandello F
    Acta Ophthalmol Scand; 2002 Dec; 80(6):667-8. PubMed ID: 12485292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic value of indomethacin in threatened abortion.
    Souka AR; Osman M; Sibaie F; Einen MA
    Prostaglandins; 1980 Mar; 19(3):457-60. PubMed ID: 6992229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of prolonged use of progesterone compounds on fetal weight].
    Hertz P; Sani L
    Akush Ginekol (Mosk); 1980 Aug; (8):24-5. PubMed ID: 7416389
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hormonal studies and clinical observations in patients with threatening abortion or premature birth, respectively treated with depot-17-alpha-hydroxyprogesterone-caproate].
    Tóth F; Kónya Z
    Z Geburtshilfe Gynakol; 1971 Oct; 175(2):168-75. PubMed ID: 5118523
    [No Abstract]   [Full Text] [Related]  

  • 20. [On combined estro-progestogenic and antireactional treatment in threatened abortion].
    Goisis M; Oppo GT
    Minerva Ginecol; 1971 Jun; 23(11):547-52. PubMed ID: 5566453
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.